Reversal of anticancer drug resistance by COTC based on intracellular glutathione and glyoxalase I

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 4, 2005, Pages 1111-1114

  Kamiya, Daisuke ^a   Uchihata, Yuki ^a   Ichikawa, Eiko ^b   Kato, Kuniki ^a   Umezawa, Kazuo ^a  

^a KEIO UNIVERSITY   (Japan)

^b MUSASHINO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GLUTATHIONE; LACTOYLGLUTATHIONE LYASE; MELPHALAN; VINBLASTINE;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL DEATH; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PANCREAS ADENOCARCINOMA;

EID: 16244364009     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.12.031     Document Type: Article

References (22)

1. D. Lautier, Y. Canitrot, R.G. Deeley, and S.P. Cole Biochem. Pharmacol. 52 1996 967
2. T. Ohmori, E.R. Podack, M. Takahashi, Y. Miyahara, Y. Takeda, N. Kubota, Y. Funayama, H. Ogasawara, and T. Ohira Biochem. Biophys. Res. Commun. 192 1993 30
3. S.J. Berger, D. Gosky, E. Zborowska, J.K. Wilson, and N.A. Berger Cancer Res. 54 1994 4077
4. J.M. Adams, and S. Cory Science 281 1998 1322
5. M.E. Anderson Chem. Biol. Interact. 111-112 1998 1
6. A.L. Vahrmeijer, C.A. Snel, D.P. Steenvoorden, J.H. Beijnen, K.S. Pang, J. Schutrups, R. Tirona, H.J. Keizer, J.H. van Dierendonck, C.J. van de Velde, and G.J. Mulder Cancer Res. 56 1996 4709
7. C. Meijer, N.H. Mulder, H. Timmer-Bosscha, W. Sluiter, G.J. Meersma, and E.G. DeVries Cancer Res. 52 1992 6885
8. W.Z. Yang, A. Begleiter, J.B. Johnston, L.G. Israels, and M.R. Mowat Mol. Pharmacol. 41 1992 625
9. K.D. Tew Cancer Res. 54 1994 4313
10. P.J. Thornalley Biochem. J. 269 1990 1
11. J.D.L. Vander J. Med. Chem. 18 1975 1155
12. J.P. Richard Biochemistry 30 1991 4581
13. P.J. Thornalley Crit. Rev. Oncol. Hematol. 20 1995 99
14. H. Sakamoto, T. Mashima, A. Kizaki, S. Dan, Y. Hashimoto, M. Naito, and T. Tsuruo Blood 95 2000 3214
15. H. Sakamoto, T. Mashima, S. Sato, Y. Hashimoto, T. Yamori, and T. Tsuruo Clin. Cancer Res. 7 2001 2513
16. T. Takeuchi, H. Chimura, M. Hamada, H. Umezawa, O. Yoshioka, N. Oguchi, Y. Takahashi, and A. Matsuda J. Antibiot. 28 1975 737
17. H. Chimura, H. Nakamura, T. Takita, T. Takeuchi, H. Umezawa, K. Kato, S. Saito, T. Tomisawa, and Y. Iitaka J. Antibiot. 28 1975 743
18. C.F.M. Huntley, D.S. Hamilton, D.J. Creighton, and B. Ganem Org. Lett. 2 2000 3143
19. T. Schnelldorfer, S. Gansauge, F. Gansauge, S. Schlosser, H.G. Beger, and A.K. Nussler Cancer 89 2000 1440
20. T.P. Akerboom, and H. Sies Methods Enzymol. 77 1981 373
21. We assume that an unidentified plausible intermediate formed from one molecule of COTC and two molecules of GSH on the process to afford SGTC might cause depletion of cellular GSH. Cf.: D.S. Hamilton, Z. Ding, B. Ganem, and D.J. Creighton Org. Lett. 4 2002 1209
22. Y. Gavrieli, Y. Sherman, and S.A. Ben-Sasson J. Cell Biol. 119 1992 493